Related Experiment Video
Updated: Mar 27, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Targeting serum calcium in chronic kidney disease and end-stage renal disease: is normal too high?
1Renal Division, Emory University School of Medicine, Atlanta, Georgia, USA.
Insights
Correcting low calcium in advanced chronic kidney disease (CKD) and end-stage renal disease (ESRD) may cause harm. Lowering calcium targets might offer benefits with minimal risks and warrants further investigation.
Area of Science:
- Nephrology
- Mineral and Bone Disorders
Background:
- Hypocalcemia is prevalent in advanced chronic kidney disease (CKD) and end-stage renal disease (ESRD).
- Current practice aims to normalize serum calcium levels, potentially preventing symptoms and managing hyperparathyroidism.
Purpose of the Study:
- To evaluate the established practice of normalizing serum calcium in CKD/ESRD.
- To explore the potential benefits and risks of targeting lower serum calcium levels.
Main Methods:
- Review of existing literature and recent data regarding calcium management in CKD/ESRD.
- Analysis of potential adverse effects of normalized calcium, including vascular calcification and adynamic bone disease.
Main Results:
- Limited evidence supports normalizing calcium levels.
- Data suggest that normalization may promote vascular calcification and adynamic bone disease.
Conclusions:
- The benefits of normalizing serum calcium in CKD/ESRD are not well-established.
- Targeting lower calcium levels may present minimal risks and significant potential benefits, meriting further research.
Abstract:
Hypocalcemia is common in advanced chronic kidney disease (CKD) and end-stage renal disease (ESRD), and it is standard practice to correct this back to the normal range, presumably to prevent symptomatic hypocalcemia and help control hyperparathyroidism. However, there are few studies to support this approach, and recent data suggest that this promotes vascular calcification and adynamic bone disease. Whether setting a lower target will improve outcomes has not been tested, but existing data suggest that this may have minimal risks and substantial potential benefits and should be explored.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Skeleton and Calcium Homeostasis
Acute Kidney Injury V: Interprofessional Care

